Paradigm Biopharmaceuticals Limited (ASX:PAR), currently under voluntary administration, has given notice that it intends to rely on relief under ASIC Corporations (Externally-Administered Bodies) Instrument 2025/584 to defer its Annual General Meeting and financial reporting obligations, following the appointment of Christopher Pattinson and Hayden White of FTI Consulting as Joint and Several Voluntary Administrators on 29 September 2026.

Key Points

  • Christopher Pattinson and Hayden White of FTI Consulting were appointed as Joint and Several Voluntary Administrators on 29 September 2026 under section 436A of the Corporations Act 2001.
  • The 2026 Annual General Meeting, otherwise required to be held by 30 November 2026, has been deferred and will not be held by that date.
  • The deferral period runs from 29 September 2026 and may extend to as long as 29 September 2028, depending on the status of external administration.
  • The 2026 Annual Report for the financial year ended 30 June 2026 was released to ASX on 28 August 2026, prior to the Administrators' appointment.
  • The company must hold an AGM within two months after the end of the deferral period and lay before it all outstanding financial reports.

Voluntary Administration and ASIC Instrument Relief

Paradigm Biopharmaceuticals disclosed that it intends to rely on sections 8 and 9 of ASIC Corporations (Externally-Administered Bodies) Instrument 2025/584, which provides for the deferral of financial reporting obligations under Part 2M.3 of the Corporations Act 2001 and the requirement to hold an Annual General Meeting under section 250N of the Act. The relief applies during the defined deferral period commencing 29 September 2026, the date of the Administrators' appointment. If the external administration ends on or before 29 March 2027, the deferral period concludes on that date.

Scope of Deferred Financial Reporting Obligations

Under section 8 of the Instrument, the company is not required to comply with a range of financial reporting obligations that would otherwise arise within 24 months of the Administrators' appointment. These include the preparation of annual and half-year financial reports, audit requirements, reporting to members, and lodgement of reports with ASIC. Specifically, the company's half-year financial report for the period ending 31 December 2026, which would otherwise be required to be lodged by 16 March 2027, is included within the deferred obligations. All deferred obligations must be met by no later than the last day of the deferral period.

AGM Deferral and 2026 Annual Report Status

The company's 2026 AGM, which would ordinarily have been required by 30 November 2026, will not proceed by that date. In accordance with the Instrument, the company must hold an AGM within two months after the end of the deferral period and lay before it all outstanding financial reports, including the 2026 Annual Report. The 2026 Annual Report for the financial year ended 30 June 2026, released on 28 August 2026 prior to administration, will be presented at the deferred AGM. The company stated that arrangements are in place to answer reasonable shareholder questions about the external administration without charge.